Afficher la notice abrégée

The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus.

dc.contributor.authorIHADDADENE, R.
dc.contributor.authorYOKOM, D. W.
hal.structure.identifierGroupe d'Etude de la Thrombose de Bretagne Occidentale [GETBO]
dc.contributor.authorLE GAL, Grégoire
hal.structure.identifierInterface Physique et Chimie pour le Vivant [IPCV]
hal.structure.identifierCentre d'Etudes Nucléaires de Bordeaux Gradignan [CENBG]
dc.contributor.authorMORETTO, P.
dc.contributor.authorCANIL, C. M.
hal.structure.identifierGroupe d'Etude de la Thrombose de Bretagne Occidentale [GETBO]
hal.structure.identifierDépartement de Médecine Interne et Pneumologie [Brest] [DMIP - Brest]
dc.contributor.authorDELLUC, Aurélien
dc.contributor.authorREAUME, N.
hal.structure.identifierThrombosis Program
hal.structure.identifierClinical Epidemiology Unit
dc.contributor.authorCARRIER, Marc
dc.date.issued2014-06
dc.identifier.issn1538-7933
dc.description.abstractEnBACKGROUND: The clinical importance of tumor thrombus in patients with renal cell carcinoma is unknown. We sought to determine the long-term risk of venous thromboembolism (VTE) in patients with residual tumor thrombus postextraction, and to evaluate the impact of residual tumor thrombus on overall survival. PATIENTS/METHODS: A cohort study of patients with stage III-IV renal cell carcinoma undergoing nephrectomy was undertaken. The primary endpoint was the risk of VTE during a 2-year follow-up period. The secondary endpoint was 2-year overall survival. RESULTS: A total of 170 surgical renal cell carcinoma patients were included, 97 (57.1%) of whom had tumor thrombus. Patients with residual tumor thrombus following surgery had a higher risk of developing VTE than those with complete tumor thrombus resection (hazard ratio [HR] 8.7, 95% confidence interval [CI] 1.7-43.4) and no tumor thrombus (HR 6.5, 95% CI 1.7-24.7). Patient with residual tumor thrombus did not have worse overall survival than those with tumor thrombus completely resected or those without tumor thrombus. CONCLUSIONS: The presence of residual tumor thrombus is an important risk factor for VTE among renal cell carcinoma patients.
dc.language.isoen
dc.publisherWiley
dc.title.enThe risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus.
dc.typeArticle de revue
dc.identifier.doi10.1111/jth.12580
dc.subject.halSciences du Vivant [q-bio]
bordeaux.journalJournal of Thrombosis and Haemostasis
bordeaux.page855-9
bordeaux.volume12
bordeaux.issue6
bordeaux.peerReviewedoui
hal.identifierhal-01026424
hal.version1
hal.popularnon
hal.audienceInternationale
hal.origin.linkhttps://hal.archives-ouvertes.fr//hal-01026424v1
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Thrombosis%20and%20Haemostasis&rft.date=2014-06&rft.volume=12&rft.issue=6&rft.spage=855-9&rft.epage=855-9&rft.eissn=1538-7933&rft.issn=1538-7933&rft.au=IHADDADENE,%20R.&YOKOM,%20D.%20W.&LE%20GAL,%20Gr%C3%A9goire&MORETTO,%20P.&CANIL,%20C.%20M.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée